April 20, 2021
Webinar, hosted by the National Centre for the 3Rs (NC3Rs UK)
This webinar forms part of the CRACK IT 10 year anniversary celebrations and will showcase an in silico platform developed to model the host response to chronic infection by Leishmania parasites, which is now delivering 3Rs benefits across other disease areas and in ecotoxicology testing. The ...
April 20, 2021 – April 21, 2021
Virtual meeting, hosted by the HESI DART Committee
The HESI DART Committee 2021 Spring Meeting will take place on April 20-21, 2021 from 9am-1pm EST. The virtual meeting is open to DART Committee participants only.
April 19, 2021 – April 20, 2021
Virtual symposium, hosted by Stanford University
Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy, research, and venture topics. This symposium provides an invaluable ...
March 18, 2021
Webinar series, hosted by the HESI Environmental Epidemiology Committee
Watch the webinar recording here.
Well-formulated epidemiologic investigations of adverse health risks associated with environmental exposures can contribute substantially to knowledge about disease ...
March 17, 2021 – March 24, 2021
Virtual meeting & ToxExpo, hosted by the Society of Toxicology (SOT)
The HESI Translational Biomarkers of Neurotoxicity (NeuTox) Committee, Developmental and Reproductive Toxicology (DART) Committee, and Botanical Safety Consortium (BSC) will present their work at the 2021 Society of Toxicology (SOT) virtual Annual Meeting & ToxExpo on 22-24 March 2021. Additionally, Dr. Syril ...
February 19, 2021 – May 21, 2021
Virtual seminar series, hosted by the HESI ITC Committee
This ITC working group seminar series aims to provide informational background on existing or newly emerging case studies of humanized mouse models from various organizations, including The Jackson Laboratory, Taconic Biosciences, AstraZeneca, and the US Food and Drug Administration. The working group seeks to better ...